1-3 of 3
Asfar Sohail Azmi, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase 1b Study

Erlene K. Seymour, MD, Yiwei Li, Amro Aboukameel, Radhakrishnan Ramchandren, Golbon Sterbis, Jay Yang, MD, Divaya Bhutani, MD, Ramzi Mohammad, PhD, Asfar Sohail Azmi, PhD, Jeff Zonder, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-140752
Published: 2020
Journal Articles

Bruton Tyrosine Kinase Inhibition in Classical Hodgkin Lymphoma Cell Lines and Animal Models

Irfana Muqbil, PhD, Amro Aboukameel, MS, Ramzi Mohammad, PhD, Asfar Sohail Azmi, PhD, Radhakrishnan Ramchandren, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1536.
https://doi.org/10.1182/blood.V130.Suppl_1.1536.1536
Published: 2017
Journal Articles

Combination of Selinexor and the Proteasome Inhibitor, Bortezomib Shows Synergistic Cytotoxicity in Diffuse Large B-Cells Lymphoma Cells In Vitro and In Vivo

Trinayan Kashyap, MS, Irfana Muqbil, Amro Aboukameel, Boris Klebanov, MA, MS, Ramzi Mohammad, PhD, Asfar Sohail Azmi, PhD, William Senapedis, PhD, Sharon Shacham, PhD MBA, Michael Kauffman, MD PhD, Yosef Landesman, PhD
Journal: Blood
Blood (2016) 128 (22): 4131.
https://doi.org/10.1182/blood.V128.22.4131.4131
Published: 2016